The insect immune deficiency (IMD) pathway resembles the tumour necrosis factor receptor network in mammals and senses diaminopimelic-type peptidoglycans present in Gram-negative bacteria. Whether unidentified chemical moieties activate the IMD signalling cascade remains unknown. Here, we show that infection-derived lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) and 1-palmitoyl-2-oleoyl diacylglycerol (PODAG) stimulate the IMD pathway of ticks. The tick IMD network protects against colonization by three distinct bacteria, that is the Lyme disease spirochete Borrelia burgdorferi and the rickettsial agents Anaplasma phagocytophilum and A. marginale. Cell signalling ensues in the absence of transmembrane peptidoglycan recognition proteins and the adaptor molecules Fas-associated protein with a death domain (FADD) and IMD. Conversely, biochemical interactions occur between x-linked inhibitor of apoptosis protein (XIAP), an E3 ubiquitin ligase, and the E2 conjugating enzyme Bendless. We propose the existence of two functionally distinct IMD networks, one in insects and another in ticks.
The immune deficiency (IMD) signalling cascade is functionally analogous to the mammalian tumour necrosis factor (TNF) receptor network, and has a critical role in arthropod humoral responses1,2. In insects, peptidoglycan recognition protein LC (PGRP-LC) and PGRP-LE sense diaminopimelic-type peptidoglycans (DAP-PGN) present in most Gram-negative bacteria. PGRP-LC interacts with the protein IMD3, which recruits the molecule Fas-Associated protein with Death Domain (FADD)4. FADD engages the caspase-8 homologue, death-related ced-3/Nedd2-like protein (DREDD)5, which cleaves IMD and uncovers a binding site for lysine (K)63-polyubiquitylation via the E3 ubiquitin ligase Inhibitor of Apoptosis Protein (IAP)26. Together with three E2 ubiquitin conjugating enzymes: Uev1a, Bendless (Ubc13) and Effete (Ubc5), IAP2 polyubiquitylates IMD in a K63-dependent manner. This leads to the recruitment of TGF-β activated kinase (TAK1) and Tak1-binding protein 2 (TAB2), which engage the I-κB kinase (IKK) complex1,2. The transcription factor Relish is then phosphorylated and the N-terminal portion (N-Rel) is cleaved by DREDD2,6. N-Rel is subsequently translocated to the nucleus and induces the production of antimicrobial peptides (AMPs)2,6.
Variations of the IMD signalling cascade indicate the existence of an uncharacterized biochemical network. For instance, deficiency in components of the IMD pathway in Drosophila renders flies susceptible to Sindbis and Cricket paralysis viruses7,8. Unlike bacterial infections, activation of the IMD pathway by viruses does not result in a robust induction of AMPs7,8. Silencing the expression of caspar, an inhibitor of the IMD pathway, curbs parasite colonization by Plasmodium falciparum and Leishmania spp. in Anopheles mosquitoes and sand flies, respectively9,10,11,12. The genome of the Chagas disease arthropod vector, Rhodnius prolixus, does not encode IMD and FADD13. Nonetheless, targeted gene silencing of relish through RNA interference (RNAi) increased the population of the symbiotic bacterium Rhodococcus rhodnii13. Along these lines, genome sequencing of the pea aphid Acyrthosiphon pisum and the body louse Pediculus humanus humanus revealed gene losses in the IMD pathway14,15 and, of particular importance to this study, comparative genomic analysis indicated the presence of an atypical IMD pathway in ticks16,17,18,19,20.
These findings suggest the existence of plasticity in the IMD pathway of arthropods. Previously, we reported that the E3 ubiquitin ligase x-linked inhibitor of apoptosis protein (XIAP) restricts bacterial colonization of Ixodes scapularis ticks21. Herein, we used a combination of structural modelling, biochemical approaches and RNAi coupled to homology transfer and interactome analysis to demonstrate that XIAP interfaces with the IMD signalling pathway by interacting with the E2 conjugating enzyme Bendless. This molecular circuit functions despite lacking several upstream signalling components including the transmembrane PGRP receptor, the death domain protein FADD and the adaptor molecule IMD. The tick IMD pathway protects against colonization by two evolutionarily divergent bacteria: the Lyme disease spirochete Borrelia burgdorferi and the rickettsial pathogen Anaplasma phagocytophilum. Interestingly, infection-derived lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) and 1-palmitoyl-2-oleoyl diacylglycerol (PODAG) stimulate the I. scapularis IMD pathway. Moreover, immune priming with POPG and PODAG protect against infection by A. phagocytophilum and A. marginale in I. scapularis and Dermacentor andersoni ticks, respectively. These findings are conceptually important because they demonstrate that the immune system of ticks diverges from what has been demonstrated in insects.
XIAP interfaces with the I. scapularis IMD pathway
In an earlier study, we determined that the I. scapularis E3 ubiquitin ligase XIAP restricts colonization of the rickettsial bacterium A. phagocytophilum in ticks21. Here we optimized the purification of recombinant XIAP by testing a range of buffers for protein solubility (Supplementary Figs 1–2). We also validated XIAP structural integrity by circular dichroism (Supplementary Fig. 2d). The protein retained the previously characterized enzymatic activity, as assessed by polyubiquitylation assays. XIAP carried out K63-dependent polyubiquitylation (Supplementary Fig. 2e, lane 1), which was ablated when a point mutation at position 63 of ubiquitin was introduced (UbK63R; Supplementary Fig. 2e, lane 4). As expected, a point mutation at position 48 (UbK48R) had no effect on XIAP enzymatic activity (Supplementary Fig. 2e, lane 3). However, there was some residual polyubiquitylation in the absence of XIAP (Supplementary Fig. 2e, lane 7), which was attributable to the previously reported autocatalytic activity of the E2 conjugating enzyme UbcH13 (ref. 22).
To determine the signalling cascade in which XIAP interfaces, we performed structural modelling and compared our results with experimentally determined structures available in the protein data bank (PDB). We threaded XIAP onto the solved structure of the E3 ubiquitin ligase cellular inhibitor of apoptosis protein 1 (cIAP1; PDB: 3T6P; Supplementary Fig. 3a) and observed that XIAP carried a non-structured region and the catalytic Really Interesting New Gene (RING) domain, but did not have either the ubiquitin-associated (UBA) or the caspase activation and recruitment domain (CARD; Supplementary Fig. 3a). I. scapularis XIAP is substantially shorter than homologues found in humans, mice and Drosophila and has different domain distributions. The tick XIAP carries only one conserved baculoviral IAP repeat (BIR) and no annotated UBA domains (Supplementary Fig. 3b)21. The predicted structure of I. scapularis XIAP revealed a model of high quality with conserved residues in the BIR domain when compared with Drosophila, mice and humans (Supplementary Fig. 3c–d)23.
The tick XIAP BIR domain carried the typically conserved zinc coordinating residues (Supplementary Fig. 3a in cyan and yellow and Supplementary Fig. 3d). Alignment of human and Drosophila BIR domains showed that the I. scapularis XIAP BIR domain belonged to the type III group (Supplementary Fig. 3e). The tick XIAP type III BIR domain demonstrated a preference for proline in the third residue of the ligand (Supplementary Fig. 3e), resembling the classic IAP-binding motif (Supplementary Fig. 3f)23. These findings provided the impetus to perform homology transfer between the tick XIAP, its homologue in humans, and the closely related protein melanoma (ML)-IAP. Homology transfer is the transposition of a function from one protein to another on the basis of their common evolutionary origin24. This method proved instrumental for functional prediction because there is a lack of empirically determined data. We acquired the top related proteins interacting with the human XIAP and ML-IAP based on previously observed protein and genetic interactions, pathways and co-localization assays (Fig. 1a,b; Supplementary Table 1). I. scapularis homologues showed an overrepresentation of immune-related genes in the XIAP interactome (Fig. 1c; Supplementary Fig. 4). In particular, six out of 14 proteins (∼43%) [P=0.01; GO:0002376 and GO:0006955] were identified from the IMD pathway: (1) Bendless, (2) Effete, (3) Uev1a, (4) IAP2, (5) TAK1 and (6) TAB2 (Fig. 1c). Overall, these findings suggested that XIAP interfaces with the IMD signalling pathway in I. scapularis during microbial infection.
XIAP interacts with the E2 conjugating enzyme Bendless
To validate the findings described above, we analysed the quantitative proteomics data deposited in the Dryad repository database25. We identified the IMD pathway E2 conjugating enzymes Bendless, Uev1a and Effete as being differentially expressed on A. phagocytophilum infection in the midgut of I. scapularis (Fig. 2a). We then used the recombinant protein XIAP (XIAP-GST) cross-linked to a glutathione agarose column to perform pull-down assays with tick cell lysates. Cross-linking did not cause steric hindrance or interfere with enzymatic activity (Supplementary Fig. 2f). Bound proteins were eluted and a peptide identified by tandem mass spectrometry resembled the E2 conjugating enzyme Bendless from the IMD pathway. Importantly, Bendless shares homology with UbcH13 (E value=1e−101), the E2 ubiquitin conjugating enzyme used in our assays (Supplementary Fig. 2e,f). Furthermore, when we docked the tick protein Bendless to XIAP in silico, the resulting model indicated that these two molecules could interact (Fig. 2b).
To confirm these results, we first incubated the recombinant forms of tick Bendless and XIAP and analysed their interactions using mobility shift assays26. Under non-denaturing conditions, XIAP was shifted to a higher molecular weight with increasing concentrations of Bendless (Fig. 2c, Supplementary Fig. 8). This observation was substantiated with an ELISA-based approach to assess binding saturation of Bendless to XIAP. With XIAP as a bait protein, increasing concentrations of Bendless bound to XIAP reaching saturation at 9.1 μM (Fig. 2d). Furthermore, Bendless and XIAP interactions were blocked with a mouse monoclonal antibody to the human homologue of Bendless in a dose-dependent manner (Fig. 2e). Next, we observed that the recombinant forms of the tick XIAP and Bendless were able to produce free K63-, but not, K48-polyubiquitin chains in an enzymatic reaction. These results were displayed with the use of wildtype ubiquitin (UbWT; Fig. 2f, lanes 1–3 and 5–10, Supplementary Fig. 9a,b); or, alternatively, with the addition of ubiquitin containing mutations at either lysine 63 (UbK63R; Fig. 2f, lane 11, Supplementary Fig. 9c) or lysine 48 (UbK48R; Fig. 2f, lane 12, Supplementary Fig. 9c).
We then employed a Human Embryonic Kidney (HEK)293 T cell transfection system with plasmids expressing the tick XIAP and Bendless (Fig. 2g, Supplementary Fig. 10a–c). Immunoblotting against FLAG and HA tags (Bendless-FLAG and XIAP-HA) demonstrated robust protein expression for Bendless and XIAP in transfected cells. When co-expressed, immunoprecipitation against the affinity tags revealed that Bendless specifically pulled down XIAP and vice versa (Fig. 2g, Supplementary Fig. 10d–e). Finally, to assess whether XIAP-Bendless interactions could occur in vivo, we extracted protein from unfed I. scapularis nymphs that had been microinjected with either siRNA targeting bendless (siBendless) or a scrambled control (scBendless). Whole tick lysates were used as bait and were incubated with increasing concentrations of recombinant XIAP. We observed that protein extracted from control ticks (scBendless) had significantly higher amounts of bound XIAP when compared with tick lysates silenced with bendless (scBendless) (Fig. 2h). Altogether, we demonstrated that XIAP and Bendless directly and specifically interact with each other through six independent approaches.
The IMD pathway restricts bacterial colonization in ticks
XIAP restricts A. phagocytophilum colonization of I. scapularis and, when silenced, confers a survival advantage for this rickettsial bacterium (Fig. 3a)21. Because Uev1a activates the human homologue of Bendless, UbcH13, to carry out polyubiquitylation27,28, we hypothesized that the same would be true for ticks. We, therefore, employed a dual knock down scheme targeting both uev1a and bendless to assess the contribution of these enzymes in the I. scapularis IMD pathway during A. phagocytophilum infection. Significant silencing was achieved for both bendless and uev1a, which caused increased A. phagocytophilum burden in tick cells when compared with the control treatment (Fig. 3b). Silencing the positive regulator of the IMD pathway, relish, also favoured A. phagocytophilum infection of tick cells (Fig. 3c), whereas the converse results were obtained when we knocked down the expression of caspar, a negative regulator of the IMD pathway (Fig. 3d). Reduced caspar expression should cause the pathway to be over-activated and, accordingly, we observed decreased A. phagocytophilum colonization of tick cells when caspar was silenced (Fig. 3d).
To determine whether the results obtained in vitro could also be observed in vivo, we placed I. scapularis ticks microinjected with siRNA for bendless/uev1a, relish, caspar and scrambled controls on mice and allowed them feed to repletion (Fig. 4). We determined gene silencing and A. phagocytophilum load as a function of 16 s rDNA in fully-engorged I. scapularis nymphs. As observed for the ISE6 cell experiments, I. scapularis ticks microinjected with the siRNA for bendless/uev1a and relish were more susceptible to A. phagocytophilum infection when compared with the control treatment (Fig. 4a,b). Conversely, silencing caspar reduced A. phagocytophilum infection of ticks (Fig. 4c). To ascertain whether the IMD pathway of ticks responded to additional Gram-negative pathogens, we infected I. scapularis ticks with B. burgdorferi, the causative agent of Lyme disease. RNAi silencing of bendless/uev1a, relish and caspar altered B. burgdorferi colonization of I. scapularis in a manner similar to A. phagocytophilum (Fig. 4d–f). In sum, we discovered that the atypical IMD signalling pathway restricts A. phagocytophilum and B. burgdorferi colonization of I. scapularis ticks.
Infection-derived lipids stimulate the IMD pathway
Both B. burgdorferi and A. phagocytophilum induced expression of AMPs triggered by the IMD but not the Toll pathway in Drosophila (Supplementary Fig. 5). These results were intriguing because neither A. phagocytophilum29 nor B. burgdorferi30 have DAP-PGN in the cell envelope, which is the canonical agonist of the IMD pathway1,2. They instead use lipids and lipid-containing molecules for structural support of the membranes31,32. We sought to determine the unidentified chemical moiety that activates the IMD signalling cascade in these systems. Hence, we conducted an unbiased lipid analysis using matrix-assisted laser desorption/ionization (MALDI)-time of flight (TOF) mass spectrometry of host-free A. phagocytophilum, as we hypothesized that lipids could be activating the tick IMD pathway (Supplementary Table 3). A glycerophospholipid putatively identified as phosphatidylglycerol - PG 34:1 (34 total acyl carbons and one unsaturation) was enriched in A. phagocytophilum-infected samples when compared with host cells alone (Supplementary Table 3). We used a pure standard of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG; also PG 34:1) for stimulation studies (Fig. 5a). Two control lipids were also selected: 1-palmitoyl-2-oleoyl diacylglycerol to match the acyl arrangement of POPG, but lacking a headgroup (PODAG; DG 34:1), and 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine (MPPC; PC 30:0) to serve as a negative control with an unmatched acyl arrangement and an unrelated headgroup (Fig. 5a).
To assess whether POPG, PODAG and MPPC could stimulate humoral immune pathways, we used the Drosophila surrogate model because pathway-specific AMPs have not yet been identified in I. scapularis. We stimulated Drosophila cells with increasing concentrations of lipids and assessed activation of either the IMD or Toll pathways by quantifying transcripts of specific AMPs: diptericin (IMD) or im1 (Toll). None of the three lipids affected the Toll pathway (Fig. 5b). However, two out of the three lipids, POPG and PODAG, caused a dose-dependent increase in diptericin, while MPPC-stimulated cells remained unchanged (Fig. 5c). Altogether, these findings indicate that POPG and PODAG specifically stimulate the IMD pathway.
To evaluate whether this stimulatory effect on the IMD pathway also occurred in ticks, we used an approach that involved first priming with the lipids and then infecting cells with A. phagocytophilum. We rationalized that pre-stimulation of tick cells with POPG and PODAG would induce the activation of the IMD pathway, conferring a survival disadvantage for the bacteria. Accordingly, Drosophila and ISE6 cells were primed with 1 ng of each lipid for six hours, corresponding to the characterized peak of IMD pathway activation33. Cells were then infected with A. phagocytophilum overnight. In agreement with previous experiments, cells treated with POPG led to a statistically significant reduction in bacterial load when compared with the naive group both in Drosophila and I. scapularis (Fig. 5d,e). Conversely, MPPC stimulation did not affect bacterial survival inside of cells when compared with the control treatment (Fig. 5d,e). PODAG, on the other hand, only conferred a protective effect in tick cells. Although we do not know the biological significance of these findings, we speculate that, as there is a divergence in the IMD signalling pathway across arthropods34, it is possible that ticks and insects respond to pathogen associated molecular patterns (PAMPs) differently on microbial infection.
We raised an antibody against the positive IMD pathway regulator, Relish. Cleavage of Relish by DREDD can be used as a rapid read-out for the activation of the IMD pathway2,6. In the tick system, Relish cleavage occurred very rapidly after DAP-PGN stimulation (Fig. 5f, Supplementary Fig. 11). Similarly, both A. phagocytophilum and infection-derived lipids, POPG and PODAG, induced the appearance of Rel-N as early as one-minute post-stimulation of the I. scapularis tick cell line ISE6 (Fig. 5f, Supplementary Fig. 11). This effect was also dose dependent (Fig. 5g, Supplementary Fig. 12). Altogether, these data suggested a molecular mechanism linking A. phagocytophilum infection with the activation of the of I. scapularis IMD pathway.
The priming with POPG and PODAG in ticks was not due to off-target signalling mechanisms. Knock-down of molecular components of the tick IMD, but not the Toll or the JAK-STAT pathways, abolished the effect that lipid priming had on bacterial survival inside tick cells (Fig. 6a–h). Silencing the expression of the heterodimeric E2 ubiquitin conjugating complex, bendless/uev1a or the E3 ubiquitin ligase xiap hampered protection against A. phagocytophilum infection (Fig. 6a–d). Conversely, targeted-gene silencing of the Toll and JAK-STAT pathways (siRNA) had no altered phenotype when compared with the control group (scRNA) (Fig. 6e–h). Collectively, our results demonstrate a mechanism by which two lipid agonists (POPG and PODAG) stimulate the IMD pathway of I. scapularis ticks.
We examined whether lipid priming offered bacterial cross-protection in another chelicerate model system. We inoculated a calf with the most prevalent tick-borne livestock pathogen A. marginale and allowed mock or Dermacentor andersoni ticks injected with POPG, PODAG and MPPC to feed. After feeding, ticks were removed and A. marginale load was measured six days post-feeding. As previously observed for the A. phagocytophilum-I. scapularis system, POPG and PODAG but not MPPC priming, was protective against bacterial infection of ticks (Fig. 6i). These results suggested that the atypical IMD signalling pathway was also functional in ticks of veterinary importance.
PGRP knockdown does not affect A. phagocytophilum infection
In insects, PGRPs can function as immune pathway receptors, negative regulators of the immune response or as effectors that kill bacteria by enzymatically breaking down peptidoglycans34. As previously mentioned, the tick genome does not encode a transmembrane PGRP-LC, which is the known IMD pathway receptor in insects. However, there are four PGRPs that are predicted to be either extracellular with amidase activity (PGRP-4: XM_002413046.1) or intracellular and non-catalytic (PGRP-1: XM_002411731.1, PGRP-2: XM_002433644.1, PGRP-3: XM_002410377.1)34. To investigate whether the encoded tick PGRPs interfaced with the IMD pathway during A. phagocytophilum infection, we silenced each PGRP individually or in combination to address potential redundancy (Supplementary Fig. 6). Although significant silencing was achieved, no difference in bacterial load was observed for any of the treatments (Supplementary Fig. 6a–e). This was in agreement with the PGRP literature, which describes affinity for peptidoglycan, but no known lipid-binding capabilities2,34.
IMD pathway divergence among arthropod subphylums
I. scapularis does not bear some components of the IMD pathway, such as transmembrane PGRPs and the signalling molecules IMD and FADD (Supplementary Fig. 7)16,17,18,19,20,34. Of significant interest, these observations are not specific to ticks, which became evident as we mined other arthropod genomes and a clear immunological pattern emerged between the branches of Arthropoda. While imd was mostly present in the Pancrustacea (Hexapods and Crustaceans), this gene was absent in Myriapods (centipedes and millipedes) and Chelicerates (ticks, spiders, mites and scorpions) (Fig. 7a). This phylogenetic relationship was consistently seen in other analyses such as with Relish, the transcription factor of the IMD pathway (Fig. 7b), and with the PGRPs (Fig. 7c), reflecting a clear divergence between Pancrustacea and Chelicerates/Myriapods. Altogether, our results provided strong evidence that two functionally distinct IMD networks exist: one previously recognized by the scientific community occurring in Hexapods and Crustacea, and another atypical pathway displayed in Chelicerates and Myriapods (Supplementary Fig. 7).
The prevailing view of humoral immunity in arthropods is largely driven by studies performed in Dipteran insects2,16,18,19,20. The assumption is that pattern recognition receptors sense pathogens and/or danger signals, which then trigger an immune response similar to what has been described in model organisms16,19,20,34. Although this paradigm has certainly advanced our knowledge of arthropod immunity, this premise carries limitations when pathways in evolutionarily distant species, such as ticks, do not resemble what has been described for insects. For example, ticks do not carry βGRPs16, which, in Drosophila, binds to the polysaccharide β-1,3 glucan from the cell wall of fungi and the lipopolysaccharide of Gram-positive bacteria1,2. Moreover, Ixodidae ticks do not have a pro-phenoloxidase system, which is essential for pathogen control in insects by melanization17,34,35,36.
In this article, we have demonstrated an immune signalling cascade in ticks with several conserved molecules from the insect IMD pathway (Bendless/Uev1a, Relish and Caspar). However, the tick IMD network also lacks upstream signalling components, such as the PGRP-LC receptor and the signalling molecules, FADD and IMD17,34. This pathway responds to infection-derived lipids, POPG and PODAG, and does not involve the encoded PGPRs in the I. scapularis genome during A. phagocytophilum infection. Interestingly, although I. scapularis does not encode a transmembrane PGRP-LC receptor, Relish is still cleaved in response to DAP-PGN exposure. It has been previously shown that soluble PGRPs are capable of recognizing DAP-PGN and may assist in activating the Drosophila IMD pathway by providing a co-receptor function to transmembrane PGRPs3. Because tick cells have only soluble PGRPs encoded in the annotated genome17,34, they may be able to recognize and respond to DAP-PGN, particularly, if invaded by intracellular bacteria.
Our findings suggest that the immune system of Chelicerates and Myriapods is fundamentally different when compared with Hexapods and Crustaceans (Fig. 7 and Supplementary Fig. 7). The conceptual implications of these results are wide in scope because it suggests that atypical IMD signalling cascades exist across Arthropoda. The notion that immune pathways in ticks diverge from insects may be expected, given their unique lifestyle when compared with other blood-feeding arthropods. For example, ticks are obligate hematophageous parasites, feeding exclusively on blood at all life stages, and are capable of transmitting a variety of disease-causing agents, including bacteria, viruses and protozoa37,38. The diverse pathosphere and relatively long life span of ticks, which can extend over 10 years for some species35, suggests that unique evolutionary pressures exist for the development of immune signalling networks to control pathogens and promote prolonged survival.
Ticks are one of the earliest lineages of terrestrial arachnids, estimated to have originated between 443 and 120 million years ago35,39,40,41. Owing to their ancient evolutionary history, there is potential for the use of ticks as model organisms to study fundamental questions in arthropod immunology as well as in higher organisms. One can envision a scientific approach where conceptual breakthroughs made in ticks can be applied to other organisms. This possibility is supported by our observation that POPG, PODAG and organisms without DAP-PGN (A. phagocytophilum and B. burgdorferi) stimulate upregulation of the Drosophila IMD pathway-specific AMP diptericin, suggesting a conserved IMD pathway across arthropods. This combinatorial strategy will: (i) permit the identification of host and microbial factors that induce or suppress immune signalling; (ii) lay the groundwork for novel insights in pathogen-vector interactions; and (iii) help to develop novel interventions for prevention of tick-borne diseases.
Bacteria and animal models
I. scapularis nymphs were obtained from the Biodefense and Emerging Infectious Diseases (BEI) Research Resources Repository from the National Institute of Allergy and Infectious Diseases (NIAID) (www.beiresources.org) at the National Institutes of Health (NIH). Adult D. andersoni (Reynold’s Creek colony) were used in all A. marginale experiments. I. scapularis ticks were maintained in an incubator at 23 °C with 85% relative humidity and a 14/10-h light/dark photo-period regimen, while D. andersoni ticks were maintained in an incubator at 25 °C with 98% relative humidity and a 12/12-hour light/dark photo-period regimen. Mouse breeding and experiments were performed in strict compliance with guidelines set forth by the NIH (Office of Laboratory Animal Welfare (OLAW) assurance numbers A3200-01, A323-01, A3270-1). Procedures were approved by the Institutional Biosafety (IBC:00002247, HP07-08, DES14-27) and Animal Care and Use (IACUC:0413017, 2014-07941, R15-34) committees at the University of Maryland, Baltimore School of Medicine, University of Maryland, College Park and Yale University of School of Medicine. C3H/HeJ mice (catalogue number 000659) were purchased from Jackson Laboratories. Mice were gender matched and at least 6–10 weeks of age. A low passage infectious isolate of B. burgdorferi B31, clone MSK5 (ref. 42) was used. A. marginale procedures were approved by the University of Idaho Institutional Animal Care and Use and Biosafety Committees (IACUC, 2013-66; Biosafety, B-010-13). A splenectomized Holstein calf (C82198) was inoculated with A. marginale-infected blood and allowed to develop acute infection.
Culturing for the A. phagocytophilum strain HZ and calculations were described elsewhere43. Briefly, A. phagocytophilum strain HZ was grown in HL-60 cells (ATCC, CCL-240), a human promyelocytic cell line, with Roswell Park Memorial Institute (RPMI) medium supplemented with 10% heat-inactivated FBS and Glutamax (Gibco, 35050-061). Cells were maintained at a concentration between 1 × 105 and 1 × 106 ml−1 at 37 °C, 5% CO2. Before isolating host-free A. phagocytophilum, bacteria were enumerated using a previously reported formula43. The percentage of infected cells is multiplied by the average number of microcolonies per cell, termed ‘morulae’ (5), the average bacteria per morulae (19) and the average amount of bacteria typically recovered from the isolation procedure (50%).
E. coli, ISE6 and Drosophila melanogaster cell cultures
E. coli cultures21 were grown overnight in lysogeny broth (LB) supplemented with appropriate antibiotics (ampicillin 100 μg μl−l). The tick cell line, ISE6, was a gift from Ulrike Munderloh at the University of Minnesota and was used for all reported in vitro tick experiments. Cells were cultured in L15C-300 medium supplemented with 10% heat inactivated fetal bovine serum (FBS, Sigma), 10% tryptose phosphate broth (Difco, 260300), 0.1% bovine cholesterol lipoprotein concentrate (MP Biomedicals, 191476; referred here as L15C-300 complete)21. Cells were grown to confluence, as assessed by an inverted light microscope, before either being seeded in 24-well plates (Celltreat, 229124) or split (1:5–1:20) in T25 flasks (Cellstar, 690-160) for culture expansion. To infect ISE6 cells, A. phagocytophilum was lysed from HL-60s using a 27-gauge needle, followed by washing with PBS. Infections were allowed to progress for 18 h before cells were collected, unless otherwise stated.
The Drosophila melanogaster cell line, S2* was a gift from Neal Silverman at the University of Massachusetts Medical School. Cells were cultured in Schneider’s Drosophila medium supplemented with 10% heat inactivated fetal bovine serum (FBS, Sigma). For bacterial infection experiments, S2* cells were seeded at 1 × 106 per well in 24-well plates with 1 μM 20-hydroxyecdysone (Sigma) for 24 h to prime the IMD pathway, as previously reported44. Positive controls for IMD and Toll pathway activation were as follows: E. coli-derived peptidoglycan (InvivoGen, tlrl-pgnek, 10 μg mL−1) stimulation for 6 h and Staphylococcus aureus infection for 20 h. For S. aureus infections, strain USA300 JE2 (MRSA) was grown overnight at 37 °C on trypticase blood agar plates (5% sheep blood, BD). Single colonies were inoculated into Tryptic Soy Broth (TSB, BD) for overnight liquid culture at 37 °C with 180 rpm shaking. Subcultures were inoculated at 1:100 in TSB in the same conditions for 2.5 h. Optical density (OD600) of the subculture was adjusted to 0.169 in sterile PBS (Gibco). Bacteria were pelleted and the OD-adjusted subcultures were washed in PBS and pelleted. Final pellets were re-suspended in Schneider’s medium as described above. Cell cultures were inoculated with S. aureus at an MOI of 1,000 or with sterile medium (mock) and cultured for 20 h at 23 °C. For antimicrobial peptide transcript production, infections or incubations were collected after 6 or 20 h corresponding to the reported peak of IMD or Toll pathway activation33.
Both bendless or xiap were amplified by PCR using the primers indicated in Supplementary Table 2. bendless was cloned with HindIII and KpnI sites into pCMV/hygro-Negative Control Vector (FLAG-tagged) (Sino Biological, Inc). Similarly, xiap was cloned with EcoRI and NotI sites into pCMV-HA (New MCS) (Received as a gift from Christopher A. Walsh; Addgene plasmid # 32530). Both constructs were confirmed by sequencing. Recombinant Bendless was generated by amplifying the gene from I. scapularis cDNA using the indicated primers in Supplementary Table 2 and was cloned into pGEX-6P-2 using BamHI and XhoI sites. Recombinant XIAP was produced using the previously reported XIAP expression plasmid21.
Mobility shift electrophoresis and western blotting
Western blotting was performed as previously described26. Briefly, proteins were separated by SDS–PAGE and transferred to PVDF membranes. Membranes were blocked with 5% milk in PBS-T (1 × phosphate-buffered saline containing 0.05% Tween 20) for 1–2 h before being incubated with primary antibodies in either 0.25% milk PBS-T or 5% BSA (Bovine Serum Albumin) in PBS (for ubiquitin antibodies) overnight at 4 °C. Primary antibodies are as follows: α-UbK63 (Millipore, 05-1308, 1:1,000), α-UbK48 (Millipore, 05-1307, 1:1,000), α-PanUb (Millipore, MABS486, 1:1,000), α-XIAP (Thermo Scientific, custom, 1:200), α-HA (Sino Biological, 100028-MM10, 1:1,000), α-FLAG (Sigma, F3165, 1:1,000), α-I. scapularis Relish (Thermo Scientific, custom, 1:750), α-β-actin (Sigma, A2103, 1:1,000), α-rabbit (Life Technologies, A16023, 1:5,000) and α-mouse (Abcam, AB97046, 1:5,000). All blots were washed and incubated with secondary antibodies for 1 h at room temperature before being visualized with Enhanced chemiluminescence (ECL) western blotting substrate (Thermo Scientific). When necessary, blots were stripped with Western Blot Stripping Buffer (Thermo Scientific). Native gel electrophoresis was performed as previously described26. Briefly, 0.2 μg of XIAP was combined with increasing amounts of Bendless, as indicated. Proteins were incubated at room temperature for 4 h followed by native PAGE analysis and immunoblotting.
0.2 μg of XIAP was coated into a high-binding 96-well plate with 0.5 M carbonate-bicarbonate (pH 9.5) at 4 °C overnight. Plates were washed with PBS-T and blocked with 10% heat-inactivated FBS in PBS followed by incubation with indicated concentrations of Bendless at room temperature for 1 hour. Equal concentration of purified GST was used as a control. Plates were washed 5X with PBS-T and incubated with the α-UbcH13 (Novus Biologicals, NB100-56357, 1:400) and the α-rabbit IgG-HRP (Abcam; 1:10,000). To evaluate in vivo binding, 0.4 μg of lysates from unfed I. scapularis nymphs microinjected with either scrambled RNA or siRNA targeting bendless were coated onto a 96-well plate with 0.5 M carbonate-bicarbonate (pH 9.5). Increasing concentrations of GST-XIAP were added at room temperature for 1 hour. Equal concentration of purified GST was used as a binding control. Plates were washed 5X with PBS-T and probed with α-GST (Calbiochem, OB03, 1:400) and α-mouse IgG-HRP (Abcam, 1: 10,000). For antibody blocking, 9.1 μM of either Bendless or BSA control were incubated with a mouse monoclonal antibody, α-UbcH13 (Novus Biologicals, H00007334-M01) with indicated titrations at room temperature for 1 h before being added to a 96-well plate coated with 0.2 μg of XIAP. Binding levels were assessed with a polyclonal rabbit antibody, α-UbcH13 (Novus Biologicals, NB100-56357, 1:400). ELISAs were developed with 3,3′,5,5′-tetramethylbenzidine (TMB) (BD Biosciences). Reactions were stopped with 1 M H2SO4 and the absorbance was measured at 450 nm with a 595-nm correction with the Bio-Rad iMark reader.
Transfection of HEK293 T cells
1 × 106 HEK293 T cells were seeded into 6-well plates for 18 h followed by 10 μl of Lipofectamine 2,000 (Invitrogen) with 4 μg of pCMV-XIAP-HA and/or pCMV-Bendless-FLAG plasmids in Opti-MEM I Reduced Serum Medium (Invitrogen). The DNA-Lipofectamine 2,000 complex was removed after 5 h and replaced with DMEM, 10% FBS and incubated for 2 days. The transfected cells were lysed in 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA and 5% glycerol with a protease inhibitor cocktail for 15 min on ice. Whole lysates were centrifuged for 30 min at 4 °C at 12,000 r.p.m. and the supernatants were collected for downstream assays. All HEK293 T cell cultures were validated to be Mycoplasma free via PCR.
The expression of both XIAP-HA and Bendless-FLAG in HEK293 T cells was validated with α-HA (Sino Biological, 100028-MM10, 1: 1,000) and α-FLAG (Sigma, F3165, 1: 1,000). 2 mg of cell lysates were incubated with 80 μL of either cross-linked α-FLAG M2 agarose beads (Sigma, A2220) or α-HA agarose beads (Pierce, 26181) at 4 °C overnight. The beads were washed three times with 50 mM Tris, 150 mM NaCl, pH 7.5. The agarose beads were boiled in 50 μl of 2 × Laemmli buffer for 5 min and analysed via Western blot.
Recombinant protein and ubiquitylation assays
E. coli cultures transformed with either pGEX-6 P-2-Bendless or pGEX-6 P-2-XIAP21 were grown to an OD600 of 0.6–0.8 and induced with 0.1 mM of IPTG overnight at 20 °C. Cells were collected at 4,000 × G for 20 min at 4 °C and resuspended in 20 mM Tris pH 8.9, 300 mM NaCl, 5% glycerol. Recombinant Bendless cell pellets were lysed using a low-volume homogenizer (Microfluidics LV1). Soluble lysates were incubated with glutathione agarose affinity purification beads (Thermo Scientific 16100) for 1 hour at room temperature. Recombinant proteins were either eluted with 10 mM of reduced glutathione in 50 mM Tris, 150 NaCl, pH 8 or had the GST-tag cleaved with 100 U of PreScission Protease in 50 mM Tris-HCL pH 7, 150 mM NaCl, 1 mM EDTA, 1 mM DTT at 4 °C overnight. Recombinant XIAP cell pellets were re-suspended in buffers with pHs ranging from 4 to 10. Samples were sonicated and fractions were separated by centrifugation at 20,000g for 30 min at 4 °C. Affinity purification proceeded as outlined above. An additional buffer exchange step was included using Amicon Ultra Tubes (Millipore, 903024) as well as a size exclusion step to purify GST-tagged XIAP using fast purification liquid chromatography (FPLC). Ubiquitylation assays were performed with the following conditions: reaction buffer (500 mM Tris pH 7.4, 10 mM DTT), Energy R Solution (Boston Biochemical, B-10), 1.2 μg XIAP, 275 ng Ube1 (Boston Biochemical, E-305), 100 ng Bendless, 100 ng Uev1a (Boston Biochemical, E2-662), 5 μg wild type ubiquitin or ubiquitin mutants (Boston Biochemical, U-100H, UM-K48R or UMK63R) and resuspended with water in a final volume of 15 μl. Reactions were allowed to proceed for 1 h at 37 °C before being stopped with stop buffer (Boston Biochemical, SK-10).
To ensure that recombinant XIAP folded properly, the secondary structure of the protein was analysed by circular dichroism (Jasco, Inc.). Protein concentrations were quantified by Bicinchoninic acid assay (BCA) (Pierce, 23225) and diluted to 5 mM for analysis. Data were collected over the spectral range from 190 nm to 260 nm at 1 nm intervals and averaged over three acquisitions. The far-ultra violet circular dichroism spectra showed a prominent minimum at 208 nm, which is consistent with a protein carrying mostly α-helical structures.
Protein pull-downs assays were carried out with recombinant GST-tagged XIAP crosslinked to glutathione agarose beads with bis(sulfosuccinimidyl)suberate (BS3, ThermoFisher, 21580), following the manufacturer’s instructions. 2.5 × 105 ISE6 cells were sonicated in 20 mM Tris pH 8.9, 150 mM NaCl, 0.01 Triton X-100 with protease inhibitors. Lysates were incubated with cross-linked XIAP for 1 hour at 4 °C. Columns were washed four times and eluted in 20 mM Tris pH 8.9, 150 mM NaCl, 10 mM DTT, 5 mM EDTA, 0.01% Triton X-100 with ‘PreScission’ protease. Eluted proteins were precipitated using trichloroacetic acid and neutralized with ice cold acetone. 100 μg of protein was digested with trypsin overnight. Samples were quenched with trifluoroacetic acid, desalted and analysed by the University of Maryland, School of Pharmacy Mass Spectrometry Facility.
The tick XIAP sequence was compared with experimentally determined structures from the protein data bank (PDB). Depiction of the least squares structural alignment of the tick (tXIAP) BIR domain and neighbors identified from the Dali server were: 1) cIAP1 BIR3 (PDB:3D9T) - z-score: 18.4; RMSD: 1.2; aligned residues: 95; identity: 35%; 2) hXIAP BIR3 (PDB:3CLX) - z-score: 16.9; RMSD: 1.5; aligned residues: 102; identity: 31%; 3) ML-IAP (PDB: 1OXN) - z-score: 17.6; RMSD: 1.3; aligned residues: 95; identity: 39%; 4) dIAP1 BIR2 (PDB: 1JD6) - z-score: 22.2; RMSD: 0.4; aligned residues: 106; identity: 36%. Structural docking was used to predict protein-protein interactions between XIAP and Bendless. BLAST searches using Bendless (B7PKK7) and XIAP (B7PF95) sequences were evaluated against the PDB. Predicted structures with the highest homology where modelled using the Multiple Mapping Method and Phyre2 programs. The software ZDOCK was used to model the XIAP-Bendless complex. Top ten predictions, which localize to a single interface were shown. Visualization was made by PyMol.
We acquired the top related proteins interacting with the human XIAP and ML-IAP based on previously observed protein and genetic interactions, pathways and co-localization assays. I. scapularis homologues were then identified based on the searches with position-specific iterated (PSI)-basic local alignment search tool (BLAST) and GeneCard. Interactomes were compiled according to GeneMANIA and visualized by Cytoscape. Candidates were grouped according to the functional gene ontology (GO) categories available at the Database for Annotation, Visualization and Integrated Discovery (DAVID).
Data sets from a previous iTRAQ (Isobaric tags for relative and absolute quantitation) experiment deposited on the Dryad repository database (http://dx.doi.org/10.5061/dryad.50kt0) were analysed for proteins of interest.
RNAi silencing and quantitative reverse transcriptase–PCR
siRNA and their scrambled controls were synthesized using the primers listed in Supplementary Table 2 and the Silencer siRNA construction Kit (Ambion, AM1620). 3 μg of siRNA or the equivalent scrambled control was transfected into 1 × 105 ISE6 cells overnight using 5 μl ml−1 of lipofectamine 2,000 (Life Sciences, 11668-019). The following day, cells were infected with A. phagocytophilum. After 18 h, cells were collected in Trizol (Ambion, 15596018) and stored at −80 °C. RNA was extracted using the PureLink RNA Mini Kit (Ambion, 12183025). cDNA was synthesized from 500 ng of RNA with the Verso cDNA Synthesis Kit (ThermoFisher, AB-1453). Gene silencing and bacterial burden were assessed by quantitative reverse transcriptase–PCR using the primers described in Supplementary Table 2. All data were expressed as means±s.e.m.
I. scapularis microinjections
Tick microinjections were done, as previously described21, with approximately 10 ng of siRNA or equivalent scrambled controls. 10 μl microdispensers (Drummond Scientific) were drawn to fine point needles using a micropipette puller (Sutter Instruments). Microinjections were performed using a micromanipulator (Narishige, Tokyo) connected to a Nanojet microinjector (Drummond Scientific). For each group, 20 ticks were microinjected with either siRNA or scRNA and were then allowed to rest for 3–24 h before being placed onto infected mice. Each group of 20 was placed on a single infected mouse. Ticks were allowed to feed to repletion and were then collected for analysis.
Lipid identification and priming assays
Host-free A. phagocytophilum was isolated and lipids were extracted using methods that were previously described45. Briefly, triplicate cell pellets were prepared from infected and uninfected cultures. Cells were re-suspended in the water volume of the Bligh and Dyer single-phase extraction solution followed by the addition of methanol and chloroform for a total lipid extraction. Total lipids were dried under a gentle stream of nitrogen and reconstituted in a 2:1 (v:v) mixture of chloroform:methanol at equal volumes. For analysis by MALDI-TOF, 1 μL was spotted followed by 1 μL of norharmane matrix at 20 mg ml−1 in the same diluent46. These triplicate samples, along with triplicate uninfected controls, were analysed in at least technical duplicate by MALDI-TOF mass spectrometry in negative mode (Bruker Daltonics Autoflex Speed MALDI-TOF; Billerica, MA) and identified according to the lipid metabolites and pathways strategy nomenclature (LIPID MAPS)47. To identify relative changes between the uninfected control and A. phagocytophilum, all mass channels from m/z 700–900 exceeding a signal:noise ratio >6 were exported and analysed further. A cluster of PG ions were upregulated at least 2-fold (by S:N ratio comparison) in A. phagocytophilum samples, dominated by a cluster of PG species containing 34 acyl carbons in unsaturated, mono-, and di-unsaturated configurations. Specifically, m/z 747.5 was identified (putative identity assigned as PG 34:1, commonly observed as palmitoyl (16:0)-oleoyl(18:1)-PG, POPG)48,49 as an ion of interest due to the dramatic increase in relative abundance compared with uninfected cells. Additionally, PG 34:0 and PG 34:2 were unique to A. phagocytophilum (Supplementary Table 3). Supplementary Table 3 highlights ions exclusive in both conditions and includes the 3 ions exceeding 2-fold detection over uninfected cells predicted to be even-carbon chain PGs. Exact masses are given from LIPID MAPS for error calculation. All organic solvents and MALDI reagents were sourced from Sigma-Aldrich (St Louis, MO).
For priming experiments, 0.01–1 ng of reference lipids (Avanti Polar Lipids, 840457, 800815 and 850445) were diluted into the tick cell culture and were added to previously seeded cells. Stimulation proceeded for 6 h, corresponding to the height of IMD pathway activity33. Media was then replaced with media containing A. phagocytophilum. Infection progressed for 18 h before samples were collected. For sequential silencing and priming experiments, targeted RNAi silencing was performed, as described earlier, before medium containing lipofectamine/RNAi was removed and replaced with lipid-containing medium.
To examine whether lipids affected A. marginale (St Maries strain) infection, we injected groups of unfed, adult male D. andersoni with individual lipids or a control. On the calf reaching a bacteremia of 1.6% (16 days post-infection; packed cell volume=36%), five cohorts of 150 adult male D. andersoni were injected, as previously described50 with either 1 ng of POPG, 1 ng of PODAG, 1 ng of MPPC, or 1 μl of chloroform/MeOH (lipid diluent control) diluted in Hanks buffered saline solution per tick and were immediately placed on the calf. Ticks were allowed to feed for six days and were then removed and held at 26 °C for seven days. Midguts from individual ticks were assessed for A. marginale infection levels using quantitative PCR and the primers described in Supplementary Table 2. The calf was killed the same day ticks were removed and had a final bacteremia=30.4% and packed cell volume=21%. 95–100% of injected ticks were recovered from their respective patches.
Relish antibody production and immunoblot
A polyclonal antibody was raised against the I. scapularis protein Relish. The protein sequence was empirically determined by amplifying relish from ISE6 cDNA using the primer combination Isc_Relish 5′ and 3′ (Supplementary Table 2). This resulting amplicon was sequenced and used to predict an amino acid sequence. Based on this, the peptide sequence REDGRATFPSMSIVFQQKK, drawn from the Rel-homology domain (RHD) portion of I. scapularis Relish, was synthesized and used to raise specific rabbit polyclonal antibodies (Pierce Antibodies, custom services). For immunoblots, ISE6 cell cultures were grown and lysed with radioimmunoprecipitation assay buffer (RIPA, Teknova, R3792) supplemented with protease inhibitors (Pierce, 88665).
Phylogenetic analysis of imd, relish and PGRPs
Imd was searched for in Arthropoda using the Basic Local Alignment Search Tool (BLAST) available through NCBI. All available arthropod genomes (tBLASTn), transcriptomes (tBLASTn) and proteomes (PSI-BLAST) were mined using the D. melanogaster IMD amino acid sequence. This BLAST analysis does not reflect overrepresentation of any genus within the subphylum. Data sets available for each subphylum are as follows: Hexapoda: 100 genomes, 231 transcriptomes. Crustacea: 3 genomes, 41 transcriptomes. Myriapoda: 1 genome, 18 transcriptomes. Chelicerata: 13 genomes, 44 transcriptomes.
The Rel homology domain sequence from D. melanogaster Relish was used to search arthropod transcripts for relish (class I) and other Rel homology domain-containing targets (dorsal and dif; class II) with tBLASTn. A multiple sequence alignment method with reduced time and space complexity (MUSCLE)51 was used to generate the multiple sequence alignment. The maximum likelihood phylogenetic tree was calculated with RAxML52 and resampled 100 times to assess clade support. The phylogenetic tree was visualized and annotated with the Interactive Tree of Life tool53. Two human NF-κB transcripts served as outgroups.
Annotated PGRP protein sequences for Aedes aegypti, Apis mellifera, Anopheles gambiae, Culex quinquefasciatus, and D. melanogaster were downloaded from NCBI. I. scapularis PGRP-1 was used to search chelicerate proteomes for PGRPs. MUSCLE was used to align the protein sequences. The maximum likelihood phylogenetic tree was calculated with RAxML and resampled 100 times to assess clade support. Bootstrap values greater than or equal to 70 are shown.
Sample sizes were chosen based on methods that have previously been reported in the literature and what has historically been appropriate to achieve statistical power21,26,54,55,56,57,58. In vitro experiments were performed with 3–5 replicates. In vivo experiment involved the use of 10-20 ticks. Data were expressed as means±s.e.m. and analysed with either the unpaired Student's t-test or one-way analysis of variance. Calculations and graphs were made by using GraphPad Prism version 6.0. P<0.05 was considered statistically significant.
Protein structural data that support the findings of this study have been deposited in the Protein Data Bank with the primary accession codes 3D9T (cIAP1 BIR3), 3CLX (hXIAP BIR3), 1OXN (ML-IAP), and 1JD6 (1JD6). iTRAQ data referenced in this study are available in the Dryad Digital Repository with the identifier http://dx.doi.org/10.5061/dryad.50kt025. Sequence data for Bendless and XIAP interactions referenced in this study are available in Uniprot with the accession codes B7PKK7 and B7PF95. Sequence date referenced in Supplementary Tables 1 and 2 are available in UnitProt or the National Center for Biotechnology Information with accession codes provided in those Supplementary Tables. Other data that support the findings of this study are available from the corresponding author on request.
How to cite this article: Shaw, D. K. et al. Infection-derived lipids elicit an immune deficiency circuit in arthropods. Nat. Commun. 8, 14401 doi: 10.1038/ncomms14401 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
We acknowledge Kimberly Stephens, Gregor Blaha (University of California, Riverside) and Sukanya Narasimhan (Yale University) for technical assistance; Ulrike Munderloh (University of Minnesota) for providing tick ISE6 cells; Jon Skare (Texas A&M Health Science Center) for providing the B. burgdorferi B31 strain, clone MSK5; Neal Silverman (University of Massachusetts Medical School) for providing S2* Drosophila cells; the Core facilities at the University of Maryland, Baltimore for services related to circular dichroism and proteomics. This work was supported by the National Institutes of Health (R01 AI093653 and R01AI116523 to J.H.F.P.) and the University of Maryland, Baltimore School of Medicine. E.E.M. was a trainee under the Institutional Training Grant T32AI007540 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/